Literature DB >> 29264672

Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.

Takuya Mizumoto1, Hirochika Toyama2, Sadaki Asari1, Sachio Terai1, Hideyo Mukubo1, Hironori Yamashita1, Sachiyo Shirakawa1, Yoshihide Nanno1, Yuki Ueda1, Keitaro Sofue3, Motofumi Tanaka1, Masahiro Kido1, Tetsuo Ajiki1, Takumi Fukumoto1.   

Abstract

BACKGROUND: The prognostic impact of pancreatic ductal adenocarcinoma (PDAC) invasion to the splenic vessel is controversial.
OBJECTIVE: The aim of this study was to assess the clinical value of pathological and radiological splenic vessel invasion in PDACs of the body and tail.
METHODS: Medical records of patients with resectable PDAC of the body and tail who underwent distal pancreatectomy between 2003 and 2016 at the Kobe University Hospital were retrospectively analyzed.
RESULTS: Overall, 68 patients (29 female and 39 male patients) were enrolled. Pathologically determined splenic vein invasion (p-SV) and splenic artery invasion (p-SA) were identified in 21 (30.9%) and 5 (7.4%) patients, respectively. The p-SV (but not p-SA) was an independent prognostic factor in multivariate analysis (p = 0.009). On analysis of recurrence patterns, patients with PDAC positive for p-SV were at a higher risk for liver metastasis (p = 0.022); however, the associations were not significant for other recurrence patterns. Liver metastasis occurred earlier in patients who were positive for p-SV (p = 0.015). Preoperative computed tomography effectively diagnosed pathological vessel invasion (SV: sensitivity, 95.2%, specificity, 72.3%; SA: sensitivity, 100%, specificity, 84.1%). Radiological SV invasion remained significant in multivariate analysis regarding postoperative survival (p = 0.007), and was also associated with early liver metastases (p = 0.008).
CONCLUSIONS: Pathological/radiological SV invasion were independent adverse prognostic factors associated with early liver metastasis in patients with PDAC of the body/tail. Assessment of these findings may be useful in determining optimal therapeutic options in these patients.

Entities:  

Mesh:

Year:  2017        PMID: 29264672     DOI: 10.1245/s10434-017-6274-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.

Authors:  Linda C Chu; Zhen J Wang; Avinash Kambadakone; Elizabeth M Hecht; Jin He; Amol K Narang; Daniel A Laheru; Hina Arif-Tiwari; Priya Bhosale; Candice W Bolan; Olga R Brook; Abraham F Bezuidenhout; Richard K G Do; Samuel J Galgano; Ajit H Goenka; Alexander R Guimaraes; David M Hough; Naveen Kulkarni; Ott Le; Lyndon Luk; Lorenzo Mannelli; Michael Rosenthal; Guillermo Sangster; Zarine K Shah; Erik V Soloff; Parag P Tolat; Marc Zins; Elliot K Fishman; Eric P Tamm; Atif Zaheer
Journal:  Abdom Radiol (NY)       Date:  2022-10-14

2.  Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.

Authors:  Kei Kitamura; Minoru Esaki; Miyuki Sone; Shunsuke Sugawara; Nobuyoshi Hiraoka; Satoshi Nara; Daisuke Ban; Takeshi Takamoto; Takahiro Mizui; Kazuaki Shimada
Journal:  Ann Surg Oncol       Date:  2022-06-12       Impact factor: 4.339

3.  Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.

Authors:  Sanne Lof; Maarten Korrel; Jony van Hilst; Adnan Alseidi; Gianpaolo Balzano; Ugo Boggi; Giovanni Butturini; Riccardo Casadei; Safi Dokmak; Bjørn Edwin; Massimo Falconi; Tobias Keck; Giuseppe Malleo; Matteo de Pastena; Ales Tomazic; Hanneke Wilmink; Alessandro Zerbi; Marc G Besselink; Mohammed Abu Hilal
Journal:  Ann Surg Oncol       Date:  2019-12-17       Impact factor: 5.344

4.  Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer.

Authors:  Feng Yin; Mohammed Saad; Jingmei Lin; Christopher R Jackson; Bing Ren; Cynthia Lawson; Dipti M Karamchandani; Belen Quereda Bernabeu; Wei Jiang; Teena Dhir; Richard Zheng; Christopher W Schultz; Dongwei Zhang; Courtney L Thomas; Xuchen Zhang; Jinping Lai; Michael Schild; Xuefeng Zhang; Hao Xie; Xiuli Liu
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-11-24

5.  Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.

Authors:  Dominique Gantois; Théophile Guilbaud; Ugo Scemama; Edouard Girard; Olivier Picaud; Marine Lefevre; Myriam Elgani; Zeinab Hamidou; Vincent Moutardier; Paul Balandraud; Mircea Chirica; Louise Barbier; David Fuks; David Jérémie Birnbaum
Journal:  Langenbecks Arch Surg       Date:  2021-08-10       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.